IL15 and neoplasm: As such, combination therapies including adoptive transfer of immune cells combined with antagonism of chemokine receptors to prevent migration towards the omentum could benefit from the addition of cytokines such as IL-15, which may serve to boost chemotaxis towards the tumour whilst also supporting and enhancing NK cell proliferation and cytotoxicity [22,34,35,37].